GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Standard Chemical & Pharmaceutical Co Ltd (TPE:1720) » Definitions » Current Deferred Revenue

Standard Chemical & Pharmaceutical Co (TPE:1720) Current Deferred Revenue : NT$0 Mil (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Standard Chemical & Pharmaceutical Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Standard Chemical & Pharmaceutical Co's current deferred revenue for the quarter that ended in Mar. 2024 was NT$0 Mil.

Standard Chemical & Pharmaceutical Co Current Deferred Revenue Historical Data

The historical data trend for Standard Chemical & Pharmaceutical Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard Chemical & Pharmaceutical Co Current Deferred Revenue Chart

Standard Chemical & Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Standard Chemical & Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Standard Chemical & Pharmaceutical Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Standard Chemical & Pharmaceutical Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard Chemical & Pharmaceutical Co (TPE:1720) Business Description

Traded in Other Exchanges
N/A
Address
No. 154, Kaiyuan Road, Xinying District, Tainan, TWN, 73055
Standard Chemical & Pharmaceutical Co Ltd is a pharmaceutical company. Along with its subsidiaries, the firm is engaged in the pharmaceutical development, manufacturing, and sales of Active Pharmaceuticals Ingredients (API), health supplements, medical equipment, neoangelac plus milk powder, and adult supplements. It offers pharmaceutical products in healthcare segments including the circulatory system, digestive system, metabolism, anti-microbial, membrane drugs, and respiratory system. The company generates a majority of its revenue from Taiwan.

Standard Chemical & Pharmaceutical Co (TPE:1720) Headlines

No Headlines